Symbol | Exchange | Currency |
|---|
Leerink Partners analyst Richard Newitter maintained a Buy rating on Nuvasive on Thursday, setting a price target of $79, which is approximately 23.53% above the present share...
Robert W. Baird analyst Jeff Johnson maintained a Hold rating on Nuvasive on Thursday, setting a price target of $70, which is approximately 9.46% above the present share price of...
NuVasive (NUVA) has received its latest FDA 510(k) clearance for the Pulse platform, after receiving CE certification earlier this summer.In addition, the Company announced the...
SPECIAL ALERT: The July episode of the Zacks Ultimate Strategy Session will be available for viewing no later than Wednesday, July 8. Kevin Matras, Jeremy Mullin, David Borun and...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Buy |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Buy |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 349.11 | 353.71 | 347.70 | -2.84 | -0.81% | 4.78M | NASDAQ | |||
| 2,678.20 | 2,705.00 | 2,670.80 | -18.9 | -0.70% | 301.69K | NASDAQ | |||
| 196.63 | 197.18 | 192.00 | -3.46 | -1.73% | 11.57M | NYSE | |||
| 198.36 | 202.20 | 196.31 | +0.86 | +0.44% | 10.66M | NASDAQ | |||
| 7.16 | 23.46 | 6.41 | -13.20 | -64.83% | 17.26M | NASDAQ | |||
| 21.74 | 21.76 | 21.53 | +0.17 | +0.79% | 4.15M | NYSE | |||
| 33.09 | 35.15 | 32.78 | -2.11 | -5.99% | 28.77M | NYSE | |||
| 227.65 | 234.69 | 226.92 | -7.75 | -3.29% | 1.31M | NASDAQ | |||
| 43.52 | 44.74 | 37.17 | +5.84 | +15.50% | 30.08M | NASDAQ | |||
| 19.36 | 19.45 | 19.00 | +0.10 | +0.52% | 3.11M | NYSE | |||
| 53.65 | 53.93 | 53.26 | -0.03 | -0.06% | 4.73M | NASDAQ | |||
| 4.44 | 4.47 | 4.44 | 0.000 | 0.00% | 0.00 | NYSE | |||
| 44.41 | 45.80 | 43.88 | -1.44 | -3.14% | 23.44M | NYSE | |||
| 30.58 | 31.71 | 29.85 | -1.29 | -4.05% | 6.30M | NYSE | |||
| 38.24 | 40.93 | 38.05 | -2.60 | -6.37% | 13.94M | NASDAQ |
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. it provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology and its intraoperative neuromonitoring services and support; and specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone. The company also offers reline fixation system that facilitates the preservation and restoration of patient alignment; integrated global alignment platform consisting of Bendini spinal rod bending system that assists with manual rod manipulation for spinal fixation; Lessray that is an image enhancement platform designed to reduce radiation exposure in the operating room, as well as Pulse, which integrates multiple enabling technologies to enhance workflow, reduce variability, and increase the reproducibility of surgical outcomes; and various biologics that are used to aid in the spinal fusion or bone healing process. In addition, it provides MAGEC, a spinal bracing and distraction system, Precice limb lengthening system, and various other products for treating specialized orthopedic procedures; onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries; and cervical artificial disc technology for cervical total disc replacement procedures. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was incorporated in 1997 and is headquartered in San Diego, California.
